Next Article in Journal
Arterial Occlusion Precipitated by Cisplatinbased Chemotherapy
Previous Article in Journal
Arterial Embolization for Ruptured Adrenal Pheochromocytoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 17
Issue 6
10.3747/co.v17i6.795
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Encouraging Data out of the 2010 Congress of the European Society for Medical Oncology with Respect to Non-Small-Cell Lung Cancer

by
Vera Hirsh
1,2,3,4
1
McGill University, Department of Medicine, Montreal, PQ H3A 1A1, Canada
2
McGill University, Department Oncology, Montreal, PQ H3A 1A1, Canada
3
McGill University, Lung Cancer Committee, Montreal, PQ H3A 1A1, Canada
4
McGill University Health Centre, Lung Administrative Tumor Group, MUHC Royal Victoria Hospital, Department of Medical Oncology, Montreal, PQ H3A 1A1, Canada
Curr. Oncol. 2010, 17(6), 7-8; https://doi.org/10.3747/co.v17i6.795
Submission received: 11 August 2010 / Revised: 7 September 2010 / Accepted: 13 October 2010 / Published: 1 November 2010

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Lung cancer continues to be the leading cause of cancer-related mortality worldwide. [...]
Keywords: metastatic NSCLC; third- or fourth-line treatment; afatinib; lux-Lung 1 metastatic NSCLC; third- or fourth-line treatment; afatinib; lux-Lung 1

Share and Cite

MDPI and ACS Style

Hirsh, V. Encouraging Data out of the 2010 Congress of the European Society for Medical Oncology with Respect to Non-Small-Cell Lung Cancer. Curr. Oncol. 2010, 17, 7-8. https://doi.org/10.3747/co.v17i6.795

AMA Style

Hirsh V. Encouraging Data out of the 2010 Congress of the European Society for Medical Oncology with Respect to Non-Small-Cell Lung Cancer. Current Oncology. 2010; 17(6):7-8. https://doi.org/10.3747/co.v17i6.795

Chicago/Turabian Style

Hirsh, Vera. 2010. "Encouraging Data out of the 2010 Congress of the European Society for Medical Oncology with Respect to Non-Small-Cell Lung Cancer" Current Oncology 17, no. 6: 7-8. https://doi.org/10.3747/co.v17i6.795

APA Style

Hirsh, V. (2010). Encouraging Data out of the 2010 Congress of the European Society for Medical Oncology with Respect to Non-Small-Cell Lung Cancer. Current Oncology, 17(6), 7-8. https://doi.org/10.3747/co.v17i6.795

Article Metrics

Back to TopTop